Wealth Enhancement Advisory Services’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.3K | Sell |
24,735
-2,716
| -10% | -$4.75K | ﹤0.01% | 3218 |
|
|
2025
Q1 | $91.4K | Buy |
27,451
+8,713
| +46% | +$29K | ﹤0.01% | 2750 |
|
|
2024
Q4 | $139K | Sell |
18,738
-5,671
| -23% | -$42K | ﹤0.01% | 2726 |
|
|
2024
Q3 | $229K | Sell |
24,409
-62
| -0.3% | -$582 | ﹤0.01% | 2341 |
|
|
2024
Q2 | $196K | Buy |
24,471
+3,565
| +17% | +$28.6K | ﹤0.01% | 2300 |
|
|
2024
Q1 | $310K | Buy |
20,906
+2,987
| +17% | +$44.3K | ﹤0.01% | 1901 |
|
|
2023
Q4 | $146K | Buy |
17,919
+281
| +2% | +$2.29K | ﹤0.01% | 2128 |
|
|
2023
Q3 | $80.3K | Buy |
+17,638
| New | +$80.3K | ﹤0.01% | 2107 |
|